These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 10922432)

  • 21. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the Multicenter Diltiazem Reinfarction Study.
    Gibson RS; Young PM; Boden WE; Schechtman K; Roberts R
    Am J Cardiol; 1987 Aug; 60(4):203-9. PubMed ID: 3303886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of diltiazem on mortality and reinfarction after myocardial infarction.
    Multicenter Diltiazem Postinfarction Trial Research Group
    N Engl J Med; 1988 Aug; 319(7):385-92. PubMed ID: 2899840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of non-Q-wave myocardial infarction: role of diltiazem versus beta-blocker therapy.
    Boden WE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S55-60. PubMed ID: 1707117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.
    Goldstein RE; Boccuzzi SJ; Cruess D; Nattel S
    Circulation; 1991 Jan; 83(1):52-60. PubMed ID: 1984898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of reinfarction subsequent to non-Q-wave infarction.
    Roberts R; Gibson RS
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S36-46. PubMed ID: 2468975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction.
    Gibson RS
    Circulation; 1989 Dec; 80(6 Suppl):IV107-19. PubMed ID: 2574639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction.
    Boden WE; Kleiger RE; Schechtman KB; Capone RJ; Schwartz DJ; Gibson RS
    Am J Cardiol; 1988 Nov; 62(16):1000-4. PubMed ID: 2973215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium antagonists in the post-myocardial infarction setting.
    Bertolet BD
    Drugs Aging; 1999 Dec; 15(6):461-70. PubMed ID: 10641957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verapamil use in patients with cardiovascular disease: an overview of randomized trials.
    Pepine CJ; Faich G; Makuch R
    Clin Cardiol; 1998 Sep; 21(9):633-41. PubMed ID: 9755379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium channel antagonists: friend or foe in postinfarction patients?
    Gibson RS; Boden WE
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):172S-176S. PubMed ID: 8968429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
    Kjeldsen SE; Hedner T; Syvertsen JO; Lund-Johansen P; Hansson L; Lanke J; Lindholm LH; De Faire U; Dahlöf B; Karlberg BE;
    J Hypertens; 2002 Jun; 20(6):1231-7. PubMed ID: 12023696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.